Literature DB >> 17978863

Expression in E. coli and tissue distribution of the human homologue of the mouse Ke 6 gene, 17beta-hydroxysteroid dehydrogenase type 8.

Shuji Ohno1, Kouki Nishikawa, Yoko Honda, Shizuo Nakajin.   

Abstract

Expression of the human Ke 6 gene, 17beta-hydroxysteroid dehydrogenase type 8, in E. coli and the substrate specificity of the expressed protein were examined. The tissue distribution of mRNA expression of the human Ke 6 gene was also studied using real-time PCR. Human Ke 6 gene was expressed as an enzymatically-active His-tag fusion protein, whose molecular weight was estimated to be 32.5 kDa by SDS-polyacrylamide gel electrophoresis. Expressed human Ke 6 gene effectively catalyzed the conversion of estradiol into estrone. Testosterone, 5alpha-dihydrotestosterone, and 5-androstene-3beta,17beta-diol were also catalyzed into the corresponding 17-ketosteroid at 2.4-5.9% that of estradiol oxidation. Furthermore, expressed enzyme catalyzed the reduction of estrone to estradiol, but the rate was a mere 2.3%. Human Ke 6 gene mRNA was expressed in the various tissues examined, such as brain, cerebellum, heart, lung, kidney, liver, small intestine, ovary, testis, adrenals, placenta, prostate, and stomach. Expression of human Ke 6 gene mRNA was especially abundant in prostate, placenta, and kidney. The levels in prostate and placenta were higher than that in kidney, where it is known to be expressed in large quantities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17978863     DOI: 10.1007/s11010-007-9637-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  13 in total

Review 1.  17beta-hydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes.

Authors:  H Peltoketo; V Luu-The; J Simard; J Adamski
Journal:  J Mol Endocrinol       Date:  1999-08       Impact factor: 5.098

2.  Localization of type 8 17beta-hydroxysteroid dehydrogenase mRNA in mouse tissues as studied by in situ hybridization.

Authors:  Georges Pelletier; Van Luu-The; Songyun Li; Fernand Labrie
Journal:  J Histochem Cytochem       Date:  2005-05-27       Impact factor: 2.479

3.  Immature ovaries and polycystic kidneys in the congenital polycystic kidney mouse may be due to abnormal sex steroid metabolism.

Authors:  D Woo; G Y Lee; E Anderson; N Aziz
Journal:  Mol Cell Endocrinol       Date:  2001-05-15       Impact factor: 4.102

Review 4.  Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase.

Authors:  V Luu-The
Journal:  J Steroid Biochem Mol Biol       Date:  2001 Jan-Mar       Impact factor: 4.292

5.  Aberrant 11beta-hydroxysteroid dehydrogenase-1 activity in the cpk mouse: implications for regulation by the Ke 6 gene.

Authors:  N Aziz; D Brown; W S Lee; A Naray-Fejes-Toth
Journal:  Endocrinology       Date:  1996-12       Impact factor: 4.736

6.  Characterization of Ke 6, a new 17beta-hydroxysteroid dehydrogenase, and its expression in gonadal tissues.

Authors:  J Fomitcheva; M E Baker; E Anderson; G Y Lee; N Aziz
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

7.  Ke 6 gene. Sequence and organization and aberrant regulation in murine polycystic kidney disease.

Authors:  M M Maxwell; J Nearing; N Aziz
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

8.  Downregulation of Ke 6, a novel gene encoded within the major histocompatibility complex, in murine polycystic kidney disease.

Authors:  N Aziz; M M Maxwell; B St Jacques; B M Brenner
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

9.  Coordinate regulation of 11 beta-HSD and Ke 6 genes in cpk mouse: implications for steroid metabolic defect in PKD.

Authors:  N Aziz; M M Maxwell; B M Brenner
Journal:  Am J Physiol       Date:  1994-11

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  6 in total

Review 1.  Regulation of 17β-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage.

Authors:  Mirja Rotinen; Joaquín Villar; Ignacio Encío
Journal:  J Physiol Biochem       Date:  2012-02-29       Impact factor: 4.158

2.  Acute prenatal exposure to a moderate dose of valproic acid increases social behavior and alters gene expression in rats.

Authors:  Ori S Cohen; Elena I Varlinskaya; Carey A Wilson; Stephen J Glatt; Sandra M Mooney
Journal:  Int J Dev Neurosci       Date:  2013-09-19       Impact factor: 2.457

Review 3.  Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery.

Authors:  Gonda Konings; Linda Brentjens; Bert Delvoux; Tero Linnanen; Karlijn Cornel; Pasi Koskimies; Marlies Bongers; Roy Kruitwagen; Sofia Xanthoulea; Andrea Romano
Journal:  Front Pharmacol       Date:  2018-09-19       Impact factor: 5.810

4.  The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better Prognosis.

Authors:  Yunmeng Nie; Fang Huang; Lihua Lou; Junbin Yan
Journal:  Med Sci Monit       Date:  2022-02-20

5.  Proteomic Identification of Heat Shock-Induced Danger Signals in a Melanoma Cell Lysate Used in Dendritic Cell-Based Cancer Immunotherapy.

Authors:  Fermín E González; Alexey Chernobrovkin; Cristián Pereda; Tamara García-Salum; Andrés Tittarelli; Mercedes N López; Flavio Salazar-Onfray; Roman A Zubarev
Journal:  J Immunol Res       Date:  2018-03-18       Impact factor: 4.818

6.  Multiple short-chain dehydrogenases/reductases are regulated in pathological cardiac hypertrophy.

Authors:  Elise Roussel; Marie-Claude Drolet; Anne-Marie Lavigne; Marie Arsenault; Jacques Couet
Journal:  FEBS Open Bio       Date:  2018-09-17       Impact factor: 2.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.